Clinical guideline seom: hereditary colorectal cancer

12Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Genetic mutations have been identified as the cause of inherited cancer risk in some colon cancer; these mutations are estimated to account for only 5–6 % of colorectal cancer (CRC) cases overall. Up to 25–30 % of patients have a family history of CRC that suggests a hereditary component, common exposures among family members, or a combination of both. Cancers in people with a hereditary predisposition typically occur at an earlier age than in sporadic cases. A predisposition to CRC may include a predisposition to other cancers, such as endometrial cancer. We describe genetics, current diagnosis and management of CRC hereditary syndromes pointing to a multidisciplinary approach to achieve the best results in patients and family outcomes.

Cite

CITATION STYLE

APA

Guillén-Ponce, C., Serrano, R., Sánchez-Heras, A. B., Teulé, A., Chirivella, I., Martín, T., … Robles, L. (2015). Clinical guideline seom: hereditary colorectal cancer. Clinical and Translational Oncology, 17(12), 962–971. https://doi.org/10.1007/s12094-015-1439-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free